Shares of EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) traded up 7.1% during mid-day trading on Monday . The company traded as high as $0.34 and last traded at $0.34. 20,000 shares traded hands during trading, an increase of 0% from the average session volume of 20,000 shares. The stock had previously closed at $0.32.
EKF Diagnostics Trading Up 7.1%
The firm has a 50-day simple moving average of $0.28 and a 200-day simple moving average of $0.33.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Further Reading
- Five stocks we like better than EKF Diagnostics
- What Are Dividends? Buy the Best Dividend Stocks
- Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500
- What is a Secondary Public Offering? What Investors Need to Know
- Value vs Growth Ratio Hits Cycle Low—Top Value Picks to Buy
- What is diluted earnings per share (Diluted EPS)?
- Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
